Robert W. Baird commented on Onyx Pharmaceuticals Inc. (Nasdaq: ONXX), following the China NDRL updated, which did not included Nexavar ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE